# Short Duration Therapy of Acute Hepatitis C Genotypes 1 or 4

> **NCT02886624** · PHASE2 · COMPLETED · sponsor: **Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba** · enrollment: 30 (actual)

## Conditions studied

- Acute Hepatitis C
- HIV

## Interventions

- **DRUG:** Grazoprevir/Elbasvir

## Key facts

- **NCT ID:** NCT02886624
- **Lead sponsor:** Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-31
- **Primary completion:** 2018-12-31
- **Final completion:** 2019-09-16
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-01-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02886624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02886624, "Short Duration Therapy of Acute Hepatitis C Genotypes 1 or 4". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02886624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*